CTSB and neoplasm: In order to enhance capivasertib delivery to oral tumor cells, capivasertib was dissolved and encapsulated into nano-matrix with the enzyme-cleavable peptidic linker GFLG, which is sensitive to the lysosomal enzyme CTSB for drug release (Figure 4A).